Gilead Sciences CDR (CAD Hedged) (GILD:TSX) closed at $33.76 on November 13, 2026, up 0.03% on the day. The stock trades 4.5% below its 52-week high of $35.36 and 37.3% above its 52-week low of $24.58. Over the past year, it gained 32.0%. Gilead Sciences CDR (CAD Hedged) is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, GILD closed higher on 118 days (47%). Its best day was July 7, 2026 (+5.22%) and its worst was November 5, 2026 (-3.96%). It never moved 10% or more in a single session.
Gilead Sciences, Inc. (Nasdaq: GILD) is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a planned $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness - while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.
Find more stocks like GILD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.